SÃO PAULO, September 3, 2026, 06:17 (BRT) — Ambev ADRs rose 3.5%, with most of the increase attributed to a broad advance in Brazilian stocks.
- Ambev ADRs finished at $2.99, gaining 3.46%, with 27.25 million shares traded.
- The local stock market rose 2.83% and the real appreciated roughly 0.57% versus the dollar.
- Organic revenue for the second quarter grew by 6.1%, while normalized EBITDA was up 8.9%.
- The average analyst price target of $3.34 implies an 11.7% upside from Wednesday’s closing price.
Ambev S.A. NYSE:ABEV ADRs climbed 3.46% to close at $2.99 on Wednesday, in line with a strong advance in Brazilian markets and not due to new company developments. After the closing bell, the stock slipped to $2.98 at 19:44 EDT Yahoo Finance.
The difference is significant for investors. Ambev’s shares in São Paulo rose 2.83%, and the real strengthened roughly 0.57%. These shifts accounted for almost the entire gain in the dollar ADR.
The surge has also narrowed the valuation gap. The consensus 12-month price target stands at $3.34, representing a premium of just 11.7% to the last close. UBS’s most recent target of $2.85 is 4.7% under the current price S&P Global analyst data.
Ambev advanced 3.8% over the past five sessions. On Wednesday, ADR volume reached 27.25 million, standing 23% under its 10-day average. This reflects a widespread rerating rather than company-driven momentum.
The Ibovespa in Brazil surged 3.05% to close at 185,205.09 points. Trading volume totaled R$40.86 billion, surpassing the daily average of R$32 billion for the year. Marco Tulli Siqueira of Necton/BTG Pactual attributed the movement to “foreign flow on the buy side” Reuters.
One-day move in context
September 2 closing changes; Brazilian real shown versus the U.S. dollar
Ambev reported a stronger operating base compared to a year ago. Organic revenue for the second quarter increased by 6.1% to R$20.15 billion. Normalized EBITDA was up 8.9%, and the margin expanded by 80 basis points to 31.6% Ambev results.
Chief Executive Carlos Lisboa said, “The consistent execution of our growth strategy translated into another quarter of beer volume growth.” The company’s normalized profit rose by 23.3% to R$3.49 billion SEC filing.
Second-quarter operating engine
Brazilian beer offered the strongest boost, as its volume increased by 5.0%, revenue advanced 8.9%, and normalized EBITDA rose 12.8%. The segment achieved a margin of 33.5%.
Results were varied in other regions. Non-alcoholic volume in Brazil decreased by 4.4%, while Latin America South saw a 2.9% reduction and Canada was down 1.8%. Central America and the Caribbean posted a 5.4% increase.
Expenses continue to be the primary operational challenge. In Brazil, beer cash costs per hectoliter climbed 4.5%, slightly outpacing a 4.4% increase in revenue per hectoliter. Ambev maintained its full-year cost growth projection at 4.5% to 7.5%.
Stronger cash generation provides backing. Operating cash flow rose 54.5% to R$4.71 billion. As of July 30, Ambev had distributed around R$5.9 billion to shareholders, covering approximately 95% of its declared buyback.
Analysts lean cautious
Eleven current recommendations: 1 strong buy, 2 buy, 6 hold, 0 sell, 2 strong sell
The upcoming week will reveal if momentum in country trades continues. Market participants are set to monitor overseas investment, the real, and polling data leading up to an additional operating update from Ambev. The company’s next scheduled cash distribution is a R$1.9 billion interest-on-capital payout on October 6.
Risks: A shift in Brazilian capital flows has the potential to remove the ADR increase seen on Wednesday. Rising commodity prices or a softer real could drive costs up to the upper end of forecasts. Weaker volumes in the region might counteract Brazil’s beer sales gains.
Related articles: NYSE:ABEV
